Conventional vs. hypofractionated radiotherapy for high-risk prostate cancer (PCS5), randomized, non-inferiority, phase III trial: Post hoc analysis of radiation therapy toxicities and efficacy of IMRT compared to 3D-CRT
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Prostate Cancer Diagnosis and Treatment
Advanced Radiotherapy Techniques
Breast Cancer Treatment Studies
Publication details
- Journal / source
- Radiotherapy and Oncology
- Volume
- 219
- Pages
- 111490–111490
- Publication date
- 27 March 2026
- Language
- EN